The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida FDA Peptide Reclassification 2026: What It Means for Providers The Amino zing World of Peptide Regulation ArentFox Schiff The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions